Picture of Medesis Pharma SA logo

ALMDP — Medesis Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Medesis Pharma FY Turnover Amounts To EUR 73,050

April 13 (Reuters) - Medesis Pharma SA  ALMDP.PA :
    * ANNUAL ACTIVITIES & RESULTS 2021
    * FOR THE FISCAL YEAR 2021 TURNOVER OF MEDESIS PHARMA
AMOUNTS TO
73,050 EUROS
    * EQUITY AMOUNTS TO 1,646,099 EUROS AS OF DECEMBER 31, 2021
    * CASH AT DECEMBER 31, 2021 AMOUNTED TO 2,889,232 EUROS
    * OUTLOOK: TO CONTINUE THE DEVELOPMENT OF 4 PRIORITY DRUG
CANDIDATES, ADVANCEMENT OF THE COLLABORATION WITH TRANSGENE AND
POSSIBLE IMPLEMENTATION OF COLLABORATIVE PROGRAMS IN OTHER
AREAS, INCLUDING THE DEVELOPMENT OF TREATMENTS FOR NUCLEAR
CONTAMINATION
    * OUTLOOK: CURRENTLY HAS SUFFICIENT CASH TO COVER ITS
ACTIVITIES
UNTIL THE END OF AUGUST 2022

Further company coverage:  ALMDP.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))

Recent news on Medesis Pharma SA

See all news